Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or death.
Keller M, Yang S, Ponor L, Bon A, Cochrane A, Philogene M, Bush E, Shah P, Mathew J, Brown AW, Kong H, Charya A, Luikart H, Nathan SD, Khush KK, Jang M, Agbor-Enoh S. Keller M, et al. Among authors: bon a. Am J Transplant. 2023 Apr;23(4):559-564. doi: 10.1016/j.ajt.2022.12.019. Epub 2023 Jan 19. Am J Transplant. 2023. PMID: 36732088 Free PMC article.
Clinical features and allograft failure rates of pulmonary antibody-mediated rejection categories.
Charya AV, Ponor IL, Cochrane A, Levine D, Philogene M, Fu YP, Jang MK, Kong H, Shah P, Bon AM, Krishnan A, Mathew J, Luikart H, Khush KK, Berry G, Marboe C, Iacono A, Orens JB, Nathan SD, Agbor-Enoh S. Charya AV, et al. Among authors: bon am. J Heart Lung Transplant. 2023 Feb;42(2):226-235. doi: 10.1016/j.healun.2022.09.012. Epub 2022 Sep 20. J Heart Lung Transplant. 2023. PMID: 36319530
Bihormonal fully closed-loop system for the treatment of type 1 diabetes: a real-world multicentre, prospective, single-arm trial in the Netherlands.
van Bon AC, Blauw H, Jansen TJP, Laverman GD, Urgert T, Geessink-Mennink J, Mulder AH, Out M, Groote Veldman R, Onvlee AJ, Schouwenberg BJJW, Vermeulen MAR, Diekman MJM, Gerding MN, van Wijk JPH, Klaassen M, Witkop M, DeVries JH. van Bon AC, et al. Lancet Digit Health. 2024 Apr;6(4):e272-e280. doi: 10.1016/S2589-7500(24)00002-5. Epub 2024 Mar 4. Lancet Digit Health. 2024. PMID: 38443309 Free article. Clinical Trial.
Type 1 interferons and Foxo1 down-regulation play a key role in age-related T-cell exhaustion in mice.
Durand A, Bonilla N, Level T, Ginestet Z, Lombès A, Guichard V, Germain M, Jacques S, Letourneur F, Do Cruzeiro M, Marchiol C, Renault G, Le Gall M, Charvet C, Le Bon A, Martin B, Auffray C, Lucas B. Durand A, et al. Among authors: le bon a. Nat Commun. 2024 Feb 26;15(1):1718. doi: 10.1038/s41467-024-45984-8. Nat Commun. 2024. PMID: 38409097 Free PMC article.
Impact of dietary n-3 polyunsaturated fatty acid intake during the perinatal and post-weaning periods on the phospholipid and ganglioside composition of olfactory tissues.
Khoury S, Soubeyre V, Cabaret S, Grégoire S, Mézière E, Masson E, Grosmaitre X, Bretillon L, Berdeaux O, Acar N, Le Bon AM. Khoury S, et al. Among authors: le bon am. Prostaglandins Leukot Essent Fatty Acids. 2023 Apr;191:102556. doi: 10.1016/j.plefa.2023.102556. Epub 2023 Feb 26. Prostaglandins Leukot Essent Fatty Acids. 2023. PMID: 36870298 Free article.
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
Chemical Synthesis, Pharmacokinetic Properties and Biological Effects of JM-00266, a Putative Non-Brain Penetrant Cannabinoid Receptor 1 Inverse Agonist.
Muller T, Demizieux L, Troy-Fioramonti S, Buch C, Leemput J, Belloir C, Pais de Barros JP, Jourdan T, Passilly-Degrace P, Fioramonti X, Le Bon AM, Vergès B, Robert JM, Degrace P. Muller T, et al. Among authors: le bon am. Int J Mol Sci. 2022 Mar 8;23(6):2923. doi: 10.3390/ijms23062923. Int J Mol Sci. 2022. PMID: 35328343 Free PMC article.
140 results